Human Immunodeficiency Virus Treatment–Induced Adipose Tissue Pathology and Lipoatrophy: Prevalence and Metabolic Consequences | Zendy

E. Hammond | Zendy; E. McKin | Zendy; David Nolan | Zendy

Open Access

Human Immunodeficiency Virus Treatment–Induced Adipose Tissue Pathology and Lipoatrophy: Prevalence and Metabolic Consequences

Author(s) -

E. Hammond,

E. McKin,

David Nolan

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/655765

Subject(s) - stavudine , lipoatrophy , adipose tissue , lipodystrophy , medicine , zidovudine , adipocyte , endocrinology , pathology , immunology , viral load , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy

Lipoatrophy and metabolic complications of treatment of human immunodeficiency virus (HIV) infection may share common associations with adipose tissue pathology and inflammation. To investigate these relationships, we undertook a large-scale study of adipose tissue, body composition, and metabolic outcomes among HIV-infected adult men at a tertiary hospital HIV cohort during the period 2001-2007.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research